Israel Englander Mi Nk Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 13,121 shares of INKT stock, worth $9,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,121
Previous 20,097
34.71%
Holding current value
$9,578
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INKT
# of Institutions
34Shares Held
912KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$170,9520.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$121,6660.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny128KShares$93,3230.0% of portfolio
-
Geode Capital Management, LLC Boston, MA96.3KShares$70,3330.0% of portfolio
-
Black Rock Inc. New York, NY87.2KShares$63,6530.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $24.7M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...